Results 141 to 150 of about 27,290 (227)

Systemic pirfenidone treatment fails to mitigate fibrosis and compromises functional recovery in a porcine model of volumetric muscle loss

Experimental Physiology, Volume 111, Issue 10, Page 4286-4295, 1 October 2026.
Abstract Repurposing clinically approved antifibrotic agents presents a potential near‐term therapeutic strategy to mitigate the extensive fibrotic scarring that follows severe volumetric muscle loss (VML) injury and inhibits functional recovery. We hypothesized that daily oral administration of pirfenidone, an FDA‐approved antifibrotic, would mitigate
Jessica M. Motherwell, Ondine Eken, Claudia E. Hernandez, Christopher L. Dearth, Stephen M. Goldman   +4 more
wiley   +1 more source

Emergence of carbapenem-resistant <i>Phytobacter diazotrophicus</i> in hospital effluent in Brazil. [PDF]

Front Microbiol
de Sousa I, Krul D, da Silva Negoseki BR, de Souza Júnior AC, Marinho ICR, Siqueira AC, Lazarotto JB, Mesa D, Conte D, Dalla-Costa LM.   +9 more
europepmc   +1 more source

Physical and Biogeochemical Ocean Response to Potential Offshore Wind Development Along the U.S. West Coast

Geophysical Research Letters, Volume 53, Issue 18, 28 September 2026.
Abstract Planning for floating offshore wind development along the U.S. west coast has prompted questions about how this new ocean use may impact marine ecosystems. Previous research suggests that offshore wind farms will alter wind dynamics and upwelling in this region, but impacts on biogeochemistry have not yet been explored.
Michael G. Jacox, Chris Chartrand, Ludivine Conte, Jerome Fiechter, Kaustubha Raghukumar, Grace Chang   +5 more
wiley   +1 more source

Frailty and the efficacy and safety of surgical versus endovascular revascularization: post-hoc analysis of the BEST-CLI trial. [PDF]

Br J Surg
Ko D, Evans PT, Park CM, Kato B, Van Over M, Conte MS, Cziraky M, Shah SJ, Pande AN, Hamburg NM, Rosenfield K, Menard MT, Farber A, Kim DH.   +13 more
europepmc   +1 more source

Editorial for the Special Issue "Advances in Molecular Microbiology, Genetics, and Bioinformatics of Multiple-Drug-Resistant Bacteria in Public Health". [PDF]

Genes (Basel)
Panzenhagen P, Conte-Junior CA.
europepmc   +1 more source

The Potential for a Benefit-Estimating Algorithm to Improve Recommendations for Preventive Services: Comparing Algorithm Recommendations with Those of Primary Care Providers. [PDF]

Med Decis Making
Conte ML, Boonstra P, Caverly TJ, Fishstrom A, Flynn A, Taksler GB, Friedman CP.   +6 more
europepmc   +1 more source

Natural killer (NK) cells with downregulated activating receptors and IL-10 production promote Trypanosoma cruzi T-cell responses in subjects in the Chronic phase of Trypanosoma cruzi infection: An exploratory immunological analysis. [PDF]

PLoS Negl Trop Dis
Elias MJ, Cesar G, Alvarez MG, Podhorzer A, Caputo MB, Lopez Albizu C, Carrega M, Tomán Conte FA, Natale MA, Albareda MC, Lococo B, Laucella SA.   +11 more
europepmc   +1 more source

Satisfactory Survivorship and Clinical Outcomes After Acetabular Revision With the Three-Dimensional-Printed Porous Metal Monoblock Dual-Mobility Cup: A Retrospective Case Series With Mean 3 Years Follow-Up. [PDF]

Arthroplast Today
Guazzoni E, Di Prima AM, Di Maio M, Anzillotti G, Conte P, Chiappetta K, La Camera F, Grappiolo G, Loppini M.   +8 more
europepmc   +1 more source

Contes i contes

Revista del Centre de Lectura de Reus, 1997
openaire   +1 more source

Posterior segment inflammation with venous involvement following a switch to a ranibizumab biosimilar (Ximluci®): a case report. [PDF]

Am J Ophthalmol Case Rep
Conte S, Nassisi M, Mainetti C, Seregni L, Viola F.   +4 more
europepmc   +1 more source